76Indexed trials
mesh condition
Psychotic Disorders
Intelligence
Psychotic Disorders intelligence: 76 indexed trials, 14 recruiting studies, 62 sponsors across 35 countries.
14Recruiting
62Sponsors
35Countries
Leading sponsors
University of North Carolina, Chapel Hill40 recruiting
King's College London31 recruiting
New York State Psychiatric Institute30 recruiting
University of Oxford21 recruiting
University of Pittsburgh20 recruiting
VA Office of Research and Development21 recruiting
University of Minnesota20 recruiting
George Washington University20 recruiting
National Institute of Mental Health (NIMH)20 recruiting
Fundación Marques de Valdecilla20 recruiting
Central Hospital, Nancy, France10 recruiting
Christina Andreou10 recruiting
Geographic activity
United States39trials
France6trials
Canada5trials
United Kingdom5trials
Spain4trials
Germany4trials
Hong Kong3trials
Switzerland3trials
South Korea2trials
Greece2trials
Bulgaria2trials
Australia2trials
Leading interventions
risperidone4trials
Risperidone3trials
Aripiprazole2trials
Treatment as Usual2trials
Olanzapine2trials
olanzapine2trials
tDCS2trials
Quetiapine2trials
Aripiprazole or Perphenazine1trials
Cannabidiol1trials
Acceptance and Commitment Therapy-based lifestyle counselling programme1trials
CRT and Social Cognition1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.